SlidesetHIVUnderstanding complexities of gut microbiome dysbiosis in HIV infected populations using a large cohor- Abigail ArmstrongView Slideset
SlidesetHIVDifferential responses of colonic ILCs to gut commensal bacteria altered during HIV infection- Moriah Castleman, PhDView Slideset
SlidesetHIVThe microbial-derived short chain fatty acid butyrate directly and differentially inhibits gut T helper cell subset activation and proliferation- Jon KibbieView Slideset
SlidesetHIVOpening Lecture: Brain-Gut-Microbiota interactions and intestinal health- Wendy Henderson, PhD, MSN, CRNPView Slideset
SlidesetHIVRole of the microbiome in HIV vaccine response heterogeneity- James Kublin, MD, MPHView Slideset
SlidesetHIVMicrobial colonization of the gut and brain development in infancy- Rebecca Knickmeyer, PhDView Slideset
SlidesetHIVMicrobial dysbiosis does not alter immune activation or disease progression in SIV-infected rhesus macaques- Alexandra OrtizView Slideset
SlidesetHIVPlasma tryptophan-kynurenine metabolites are altered with gut microbiota dysbiosis in HIV infection and associated with progression of carotid artery atherosclerosis- Qibin Qi, PhDView Slideset
SlidesetHIVCervicovaginal microbial dynamics and its impact on HIV acquisition risk- Douglas Kwon, MD, PhDView Slideset
SlidesetHIVVaginal lactic acid inhibits production of pro-inflammatory mediators from human cervicovaginal epithelial cells associated with HIV acquisition- Gilda TachedjianView Slideset
SlidesetHIVModulation of gut microbiota by indoleamine 2,3-dioxygenase 1 inhibitor during antiretroviral suppressed SIV infection in rhesus macaques- Zhang WangView Slideset
SlidesetHIVEffect of high-risk sexual behaviouron diversity of the vaginal microbiota and abundance of lactobacillus- Jocelyn WesselsView Slideset
